A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Trial Identifier: D7830C00002
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT04483947
Start Date: November 2020
Primary Completion Date: December 2023
Study Completion Date: December 2023
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Chula Vista, CA, US, 91911
US, CA La Mesa, CA, US, 91942
US, CA Montclair, CA, US, 91763
US, CA San Diego, CA, US, 92103
US, FL Doral, FL, US, 33166
US, FL Hialeah, FL, US, 33014
US, FL Hialeah, FL, US, 33016
US, FL Miami Lakes, FL, US, 33014
US, IN Indianapolis, IN, US, 46202
US, NC Morehead City, NC, US, 28557
US, OH Columbus, OH, US, 43213
US, PA Hershey, PA, US, 17033
US, TX Arlington, TX, US, 76012
US, TX Dallas, TX, US, 75203
US, TX San Antonio, TX, US, 78229
US, TX San Antonio, TX, US, 78215